SelectQuote Inc

SelectQuote Inc (SLQT) Stock Analysis

$0.390

-0.080 (-20.61%)At close

Loading chart…
High
0.496
Open
0.484
VWAP
0.42
Volume
2.03M
Mkt Cap
463.49M
Low
0.360
Amount
844.31K
EV/EBITDA, TTM
3.64

SelectQuote, Inc. provides a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. The Company has four core business lines: SelectQuote Senior, SelectQuote Healthcare Services, SelectQuote Life, and SelectQuote Auto and Home. SelectQuote’s Senior division sells Medicare Advantage, Medicare Supplement, Medicare Part D, and other ancillary senior health insurance related products. SelectQuote Healthcare Services comprises SelectRx Pharmacy, a specialized medication management pharmacy, and Population Health which proactively connects its members with healthcare services that fit each member's healthcare needs. SelectQuote’s Auto & Home division primarily sells non-commercial auto and home, property and casualty insurance products. SelectQuote’s Life division sells term life, final expenses, and other ancillary products. SelectRx is a Patient-Centered Pharmacy Home (PCPH) accredited pharmacy.

AI analysis of SelectQuote Inc (SLQT)

Buy

SelectQuote Inc (SLQT) appears to be a good buy right now due to its recent price momentum and favorable valuation metrics. The current price is $0.402, which is significantly below its 52-week high of $2.17, indicating potential for recovery. The stock has shown a 5-day change of +22.90%, reflecting strong short-term performance. Additionally, the forward P/E ratio is 66.67, suggesting that while the stock is expensive based on earnings, it is trading at a low price-to-sales ratio of 0.0395, indicating it may be undervalued relative to its sales. However, the main risk is the negative earnings per share (EPS) estimate of -0.26 for the upcoming quarter, which could lead to further volatility.

Valuation Metrics

The current forward P/E ratio for SelectQuote Inc (SLQT) is 66.67, compared to its 5-year average forward P/E of 2.48.

Forward P/E

Overvalued
5Y Average P/E
2.48
Current P/E
66.67
Overvalued
48.70
Undervalued
-43.74

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
1.71
Current EV/EBITDA
3.64
Overvalued
54.04
Undervalued
-50.62

Forward P/S

Fair
5Y Average P/S
0.29
Current P/S
0.06
Overvalued
0.56
Undervalued
0.03

Alphio AI Price Scenarios for SLQT

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%SLQT

$2.27

Scenario price

B

Base

Base · 50%SLQT

$2.16

Scenario price

B

Bear

Bear · 25%SLQT

$1.66

Scenario price

Whales holding SLQT

A

Abrams Bison Investments, L.L.C.

+ HoldingSLQT

+8.79%

3M Return

Events Timeline

2026-11-04 (ET)

07:30:00

SelectQuote Reports Q1 Revenue of $280M

07:30:00

Sees FY27 Adjusted EBITDA of $90M-$115M

2026-08-25 (ET)

16:30:00

Major Averages Rise as Chip Stocks Benefit from Nvidia Earnings

12:30:00

Major Averages Slightly Higher, Chip Stocks Benefit from Nvidia Earnings

07:30:00

SelectQuote Q4 Revenue $321.7M, Below Consensus

News

SLQT FAQ — answered by Alphio AI

SelectQuote, Inc. provides a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. The Company has four core business lines: SelectQuote Senior, SelectQuote Healthcare Services, SelectQuote Life, and SelectQuote Auto and Home. SelectQuote’s Senior division sells Medicare Advantage, Medicare Supplement, Medicare Part D, and other ancillary senior health insurance related products. SelectQuote Healthcare Services comprises SelectRx Pharmacy, a specialized medication management pharmacy, and Population Health which proactively connects its members with healthcare services that fit each member's healthcare needs. SelectQuote’s Auto & Home division primarily sells non-commercial auto and home, property and casualty insurance products. SelectQuote’s Life division sells term life, final expenses, and other ancillary products. SelectRx is a Patient-Centered Pharmacy Home (PCPH) accredited pharmacy. It operates in the Financials sector (INSURANCE AGENTS, BROKERS & SERVICE industry).

SelectQuote Inc (SLQT) appears to be a good buy right now due to its recent price momentum and favorable valuation metrics. The current price is $0.402, which is significantly below its 52-week high of $2.17, indicating potential for recovery. The stock has shown a 5-day change of +22.90%, reflecting strong short-term performance. Additionally, the forward P/E ratio is 66.67, suggesting that while the stock is expensive based on earnings, it is trading at a low price-to-sales ratio of 0.0395, indicating it may be undervalued relative to its sales. However, the main risk is the negative earnings per share (EPS) estimate of -0.26 for the upcoming quarter, which could lead to further volatility.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading